Ben Blue

In this intriguing discussion, Dr. Ben Blue, CEO of Ora Biomedical and co-founder of the WormBot platform, shares insights into groundbreaking longevity research. He reveals how the Million Molecule Challenge aims to transform drug discovery for aging by identifying powerful new molecules. Notably, Dr. Blue discusses omipalisib, a molecule outperforming rapamycin, and the team's strategic pivot towards radiation resilience for space applications. They explore the significance of a data-driven approach and unexpected findings from their high-throughput screenings.